Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos
- PMID: 9581816
Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos
Abstract
Alterations in the FHIT gene region have been previously associated with smoking status and the occurrence of lung tumors. In the current study, we examined the nature of the mutations that occur at FHIT and the types of carcinogen exposures that are associated with FHIT alterations. We screened 40 primary lung tumors for the presence of point mutations within the coding exons of FHIT using PCR-single-strand conformational polymorphism. Tumors were also analyzed for allelic loss using microsatellite markers located in or near FHIT. No tumors contained point mutations within the coding region of the FHIT gene. However, several samples failed to generate a PCR product, suggesting that regions of the gene are homozygously deleted. Samples were reanalyzed for exon loss using PCR; 13 of 30 tumors failed to generate a PCR product, and 20 of 30 tumors were missing at least one FHIT exon or had loss (loss of heterozygosity or deletion) of one microsatellite marker, suggesting that regions of the gene are homozygously deleted. These data indicate that the FHIT gene has a novel pattern of mutational inactivation not seen previously with other tumor suppressor genes, most likely influenced by the proximity of the FRA3B region. There were no associations of age, sex, p53, or k-ras mutation and FHIT exon deletion. However, there was an association of smoking duration and asbestos exposure with FHIT exon loss, indicating that carcinogenic exposures may be causal in the generation of alterations in the FHIT region.
Similar articles
-
FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.Cancer Res. 1997 Jun 1;57(11):2256-67. Cancer Res. 1997. PMID: 9187130
-
Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.Cancer Res. 1997 Sep 1;57(17):3664-8. Cancer Res. 1997. PMID: 9288768
-
Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.Cancer Res. 1998 Jun 15;58(12):2533-6. Cancer Res. 1998. PMID: 9635574
-
The Fragile Histidine Triad gene and breast cancer.Med Sci Monit. 2002 Jul;8(7):RA140-4. Med Sci Monit. 2002. PMID: 12118213 Review.
-
The role of the FHIT/FRA3B locus in cancer.Annu Rev Genet. 1998;32:7-31. doi: 10.1146/annurev.genet.32.1.7. Annu Rev Genet. 1998. PMID: 9928473 Review.
Cited by
-
Genomic impact of cigarette smoke, with application to three smoking-related diseases.Crit Rev Toxicol. 2012 Nov;42(10):877-89. doi: 10.3109/10408444.2012.725244. Epub 2012 Sep 18. Crit Rev Toxicol. 2012. PMID: 22989067 Free PMC article. Review.
-
A population-based study of immunohistochemical detection of p53 alteration in bladder cancer.Br J Cancer. 2004 Apr 19;90(8):1572-6. doi: 10.1038/sj.bjc.6601748. Br J Cancer. 2004. PMID: 15083187 Free PMC article.
-
Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis.World J Gastroenterol. 2005 Jan 14;11(2):228-31. doi: 10.3748/wjg.v11.i2.228. World J Gastroenterol. 2005. PMID: 15633221 Free PMC article.
-
Genetic and epigenetic tumor suppressor gene silencing are distinct molecular phenotypes driven by growth promoting mutations in nonsmall cell lung cancer.J Cancer Epidemiol. 2008;2008:215809. doi: 10.1155/2008/215809. Epub 2009 Jan 28. J Cancer Epidemiol. 2008. PMID: 20445774 Free PMC article.
-
Asbestos, Smoking and Lung Cancer: An Update.Int J Environ Res Public Health. 2019 Dec 30;17(1):258. doi: 10.3390/ijerph17010258. Int J Environ Res Public Health. 2019. PMID: 31905913 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials
Miscellaneous